Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;28(1):31-45.
doi: 10.1016/j.jsha.2015.05.003. Epub 2015 May 19.

Novel oral anticoagulants and the 73rd anniversary of historical warfarin

Abdulla Shehab  1 , Asim Ahmed Elnour  2 , Akshaya Srikanth Bhagavathula  3 , Pınar Erkekoglu  4 , Farah Hamad  5 , Saif Al Nuaimi  6 , Ali Al Shamsi  6 , Iman Mukhtar  7 , AbdElrazek M Ali AbdElrazek  8 , Aeshal Al Suwaidi  7 , Mahmoud Abu Mandil  7 , Mohamed Baraka  9 , Adel Sadik  7 , Khalid Saraan  10 , Naama M S Al Kalbani  6 , Alaa AbdulAziz Mahmood  11 , Yazan Barqawi  7 , Mohammed Al Hajjar  7 , Omer Abdulla Shehab  1 , Abdulla Al Amoodi  1 , Sahar Asim  5 , Rauda Abdulla  1 , Cristina Sanches Giraud  12 , El Mutasim Ahmed  7 , Zohdi Abu Shaaban  7 , Ahmed Eltayeb Yousif Ahmed Eltayeb  13
Affiliations
Review

Novel oral anticoagulants and the 73rd anniversary of historical warfarin

Abdulla Shehab et al. J Saudi Heart Assoc. 2016 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Karl link promoting warfarin as a rodenticide (courtesy of University of Wisconsin).
Figure 2
Figure 2
Karl link in his laboratory (courtesy of University of Wisconsin).
See this image and copyright information in PMC

References

    1. Duxbury B.M., Poller L. The oral anticoagulant saga: past, present, and future. Clin Appl Thromb Hemost. 2001;7(4):269–275. - PubMed
    1. Ghate S.R., Biskupiak J.E., Ye X., Hagan M., Kwong W.J., Fox E.S. Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis. Ann Pharmacother. 2011;45(6):701–712. - PubMed
    1. LaHaye S.A., Gibbens S.L., Ball D.G., Day A.G., Olesen J.B., Skanes A.C. A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation. Eur Heart J. 2012;33(17):2163–2171. - PMC - PubMed
    1. Granger C.B., Alexander J.H., McMurray J.J., Lopes R.D., Hylek E.M., Hanna M. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–992. - PubMed
    1. Giugliano R.P., Ruff C.T., Braunwald E., Murphy S.A., Wiviott S.D., Halperin J.L. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093–2104. - PubMed

LinkOut - more resources